Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma

BACKGROUND: Germline genetic testing for familial cancer syndromes is usually performed serially for the most likely genetic causes. In recent years the way genetic testing carried out has changed, as next generation sequencing now allows the simultaneous testing of multiple susceptibility genes at...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Heitzer, Ellen, Lax, Sigurd, Lafer, Ingrid, Müller, Stephanie M, Pristauz, Gunda, Ulz, Peter, Jahn, Stephan, Högenauer, Christoph, Petru, Edgar, Speicher, Michael R, Geigl, Jochen B
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3913615/
https://ncbi.nlm.nih.gov/pubmed/24373500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2350-14-129
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars